Monoclonal Antibody to murine Ido1 (indoleamine 2, 3-dioxygenase 1), produced in E.Coli.
| Inventor | Institute |
|---|---|
| Muriel Moser | Free University of Brussels |
| Cat. #: | 152145 |
|---|---|
| Tool sub type: | Primary antibody |
| Research Fields: | Cancer;Cell signaling and signal transduction;Metabolism;Tissue-specific biology |
| Application: | FACS ; WB |
| Target: | Ido1 (inodleamine 2, 3-dioxygenase 1) |
| Reactivity: | Mouse |
| Clone: | 8G11 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | The Ido1-8G11 mAb reacts to murine Ido1 with a possible crossreaction to murine Ido2, a gene sharing multiple homologies with Ido1 and encoded by a distinct gene located on the same locus on chromosome 8. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2a kappa |
| Immunogen: | Recombinant murine Ido1 (indoleamine 2,3-dioxygenase 1), produced in E. Coli |
| Target background: | The Ido1-8G11 mAb reacts to murine Ido1 with a possible crossreaction to murine Ido2, a gene sharing multiple homologies with Ido1 and encoded by a distinct gene located on the same locus on chromosome 8. |
|---|
| Storage conditions: | Shipping at 4° C |
|---|---|
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.